SpaceOAR Vue Hydrogel
What is the benefit of hydrogel spacing and a radiopaque perirectal spacer?
SpaceOAR Hydrogel is an absorbable hydrogel that temporarily creates space between the prostate and rectum, designed to reduce the radiation dose delivered to the rectum during prostate cancer radiation therapy.
The enhanced visibility on a CT scan is designed to help physicians improve contouring accuracy of the prostate and rectum, potentially leading to more accurate treatment plan creations when compared to SpaceOAR™ Hydrogel. This may reduce the overall treatment costs per patient, time required to fuse CT and MRI images, and the hospital staff’s time spent in obtaining MRI reimbursement authorisation.
Potential Operational Benefits
With the improved visibility of SpaceOAR Vue Hydrogel on a CT scan, adepartment’s clinical workflow may be improved as the patient will not need a post-procedural MRI for treatment planning.
Potential Clinical Benefits
For CT planning, physician-delineated prostate volume can be on average 15% smaller (under contouring) or 30% larger (over contouring) than the “true” prostate volume. With SpaceOAR Vue Hydrogel, you may be able to contour the prostate and rectum without the need for an additional MRI. This may also reduce any contouring inaccuracies, potentially leading to more accurate treatment plan creations. Accurate and consistent positioning of the patient from one fraction to the next is important to physicians, to ensure that treatment is delivered according to plan. CT radiopacity may provide an effective imaging option to MRI for patients with implanted metallic devices so you can care for a broader population of prostate cancer patients.
Hydrogel Spacing: Why?
Listen to radiologist Prof. Michelle McNicholas share her experience using SpaceOAR VueTM Hydrogel
Clinical Evidence
Discover latest clinical study results around hydrogel spacing in different treatment modalities.
Interested in SpaceOAR Vue Hydrogel?
What prostate cancer patients say
Patients treated with SpaceOAR Hydrogel report a higher quality of life after prostate cancer radiation
treatment and experience minimal adverse side effects.1
Indications, Safety and Warnings
References
1. Data on file with Boston Scientific.
2. Mariados N, Sylvester J, Shah D, et al. Hydrogel spacer prospective multicenter randomized controlled pivotal trial: Dosimetric and clinical effects of perirectal spacer application in men undergoing prostate image guided intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):971-7.
Disclaimer
Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. Please check availability with your local sales representative or customer service.
All images are the property of Boston Scientific. All trademarks are the property of their respective owners.